Abstract
The detection of left ventricular hypertrophy (LVH) is recommended for risk prediction, and changes in LV geometry may provide further prognostic information. Obesity is a major determinant of LVH, but the approach to LVH detection in obese hypertensives remains a challenge. In the present review, we discuss evidence leading to the recent acceptance of the use of LV mass indexed to height2.7 or height1.7 rather than body surface area, for LVH detection and its regression in obesity. We also review recent findings which indicate that obesity-induced LVH may be associated with concentric LV remodeling, and hence, that the presence of concentric LVH in obesity should not be assumed to indicate a cause of LVH other than obesity. We also discuss recent evidence for obesity and blood pressure producing additive and interactive effects on LV mass, and hence, that weight loss and blood pressure reduction are required to achieve appropriate regression.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334–41.
Verdecchia P, Angeli F, Borgioni C, et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens. 2003;16:895–9.
Gerdts E, Cramariuc D, de Simone G, et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008;9:809–15.
Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995;25:879–84.
Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159–219.
Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557–67.
Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014;56:391–400.
de Simone G, Izzo R, De Luca N, Gerdts E. Left ventricular geometry in obesity: is it what we expect? Nutr Metab Cardiovasc Dis. 2013;23:905–12.
Chirinos JA, Segers P, De Buyzere ML, et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension. 2010;56:91–8. This paper introduced the allometric exponent of 1.7 which eliminated the residual negative relationship between LVM indexed to height 2.7 and height. Sex- and ethnic-specific thresholds of LVM indexed to body surface area and height 1.7, as well as comparisons of the prognostic values of LVM indexed to body surface area, height 2.7 and height 1.7 are provided.
Sibiya MJ, Norton GR, Hodson B, et al. Gender-specific contribution of aortic augmentation index to variations in left ventricular mass index in a community sample of African ancestry. Hypertens Res. 2014;37:1021–7.
Booysen HL, Woodiwiss AJ, Sibiya MJ et al. Indexes of aortic pressure augmentation markedly underestimate the contribution of reflected waves toward variations in aortic pressure and left ventricular mass. Hypertension. 2015 (in press).
de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251–60.
de Simone G, Kizer JR, Chinali M, et al. Normalization for body size and population—attributable risk of left ventricular hypertrophy. The Strong Heart Study. Am J Hypertens. 2005;18:191–6.
Paajanen TA, Oksala NK, Kuukasjarvi P, et al. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J. 2012;31:1802–9.
de Simone G, Devereux RB. Method errors or unexplained biological information? Hypertension. 2010;56:e177–8. This letter compared the prognostic values of LVM indexed to body surface area, height 2.7 and height 1.7 and emphasized the importance of population attributable risk.
Poppe KK, Edgerton Bachmann M, Triggs CM, et al. Geographic variation in left ventricular mass and mass index: a systematic review. J Hum Hypertens. 2012;26:420–9.
Lang RM, Bierig M, Devereux R, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;8:1440–63.
Aurigemma GP, de Simone G, Fitzgibbons TP. Cardiac remodelling in obesity. Circ Cardiovasc Imaging. 2013;6:142–52.
Messerli FH, Sundgaard-Riise K, Reisin E, et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med. 1983;99:757–61.
Bastien M, Poirier P, Lemieux I, Despres J-P. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81.
Gerdts E, de Simone G, Lund BP, et al. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. Nutr Metab Cardiovasc Dis. 2013;23:122–9.
Woodiwiss AJ, Libhaber CD, Majane OHI, et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens. 2008;21:1144–52.
Turkbey EB, McClelland RL, Kronmal RA, et al. The impact of obesity on the left ventricle: the multi-ethnic study of atherosclerosis (MESA). JACC Cardiovasc Imaging. 2010;3:266–74. This large study (over 5000 participants) assessed the impact of obesity on left ventricular mass and geometry using cardiac magnetic resonance imaging (MRI), hence avoiding the possibility of poor echocardiographic windows in obesity.
Neeland IJ, Gupta S, Ayers CR, et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging. 2013;6:800–7. In this large study (2710 participants) dual energy x-ray absorptiometry and magnetic resonance imaging were used to assess fat distribution. Visceral adipose tissue (central obesity) was shown to be associated with concentric LV remodelling; whereas lower body subcutaneous fat was associated with eccentric LV remodelling.
Kardassis D, Bech-Hanssen O, Schonander M, et al. The influence of body composition, fat distribution, and sustained weight loss on left ventricular mass and geometry in obesity. Obesity. 2012;20:605–11.
Cuspidi C, Rescaldani M, Sala C, Grassi G. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014;32:16–25. This is a meta-analysis of echocardiographic studies showing that although obesity is largely associated with eccentric LV remodelling, a significant proportion of concentric LV remodelling was also observed. It is important to note that no adjustments for either the presence of hypertension or blood pressure were made in these studies.
Khouri MG, Peshock RM, Ayers CR, et al. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging. 2010;3:129–31.
Owan T, Avelar E, Morley K, et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J Am Coll Cardiol. 2011;57:732–9.
Hsuan C-F, Huang C-K, Lin J-W, et al. The effect of surgical weight reduction on left ventricular structure and function in severe obesity. Obesity. 2010;18:1188–93. An intervention study assessing changes in LV mass and geometry 3 months after bariatric surgery, which showed that blood pressure reduction was the most important determinant of the regression of LV mass and relative wall thickness.
Luaces M, Cachofeiro V, Najar B+G-M-A, et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol. 2012;65:14–21.
Cuspidi C, Rescaldami M, Tadic M, et al. Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. Am J Hypertens. 2014;27:146–56. A meta-analysis of 23 bariatric surgery studies showing that a significant decrease in relative wall thickness (and hence a less concentric LV geometry) occurred together with reductions in LVM and LVM indexed to height 2.7.
de las Fuentes L, Waggoner AD, Mohammed S, et al. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol. 2009;54:2376–86.
Rider OJ, Lewandowski A, Nethononda R, et al. Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging. Eur Heart J. 2013;34:292–9.
de Gonzalez BA, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2011;363:2211–9.
Palatini P, Saladini F, Mos L, et al. Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients. Int J Obesity. 2013;37:224–9.
Gidding SS, Liu K, Colangelo LA, et al. Longitudinal determinants of left ventricular mass and geometry: the coronary risk development in young adults (CARDIA) study. Circ Cardiovasc Imaging. 2013;6:769–75. This is a large (2426 participants) longitudinal study which identified the determinants of increases in LV mass and relative wall thickness over 20 years.
Avelar E, Cloward TV, Walker JM, et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension. 2007;49:34–9.
Norton GR, Majane OHI, Libhaber E, et al. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity. J Hypertens. 2009;27:1873–83.
Simone G, Devereux RB, Izzo R, et al. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J Am Heart Assoc. 2013;2:e000144. This is a longitudinal study which assessed the predictors of LVM regression.
Compliance with Ethics Guidelines
Conflict of Interest
Angela J. Woodiwiss and Gavin R. Norton declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
The authors data described in this article were part of studies conducted according to the principles outlined in the Helsinki declaration and approved by the Committee for Research on Human Subjects of the University of the Witwatersrand (approval numbers M02-04-72, renewed as M07-04-69 and M12-04-108). Participants gave informed consent. This article does not contain any studies with animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Hypertension and Obesity
The authors are supported by the Medical Research Council of South Africa, the University Research Council of the University of the Witwatersrand, the National Research Foundation, the Circulatory Disorders Research Trust, and the Carnegie Corporation.
Rights and permissions
About this article
Cite this article
Woodiwiss, A.J., Norton, G.R. Obesity and Left Ventricular Hypertrophy: The Hypertension Connection. Curr Hypertens Rep 17, 28 (2015). https://doi.org/10.1007/s11906-015-0539-z
Published:
DOI: https://doi.org/10.1007/s11906-015-0539-z